CLS Receives New CPT® Reimbursement Code Approval by American Medical Association for Ultrasound-Guided Focal Laser Ablation of Prostate Cancer
November 04, 2020 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the American Medical Association (AMA) has approved its application and issued a...
CLS and University Hospital Magdeburg launch clinical trial regarding focal laser ablation treatment of localized prostate cancer
October 12, 2020 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems (publ) and Otto-von-Guericke-University Magdeburg, Medical faculty are entering into an agreement regarding an...
CLS and University Hospital Magdeburg launch clinical trial regarding focal laser ablation treatment of localized prostate cancer
October 12, 2020 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems (publ) and Otto-von-Guericke-University Magdeburg, Medical faculty are entering into an agreement regarding an...